Cargando…
Community Consensus Guidelines to Support FAIR Data Standards in Clinical Research Studies in Primary Mitochondrial Disease
Primary mitochondrial diseases (PMD) are genetic disorders with extensive clinical and molecular heterogeneity where therapeutic development efforts have faced multiple challenges. Clinical trial design, outcome measure selection, lack of reliable biomarkers, and deficiencies in long‐term natural hi...
Autores principales: | Karaa, Amel, MacMullen, Laura E., Campbell, John C., Christodoulou, John, Cohen, Bruce H., Klopstock, Thomas, Koga, Yasutoshi, Lamperti, Costanza, van Maanen, Rob, McFarland, Robert, Parikh, Sumit, Rahman, Shamima, Scaglia, Fernando, Sherman, Alexander V., Yeske, Philip, Falk, Marni J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936395/ https://www.ncbi.nlm.nih.gov/pubmed/35317023 http://dx.doi.org/10.1002/ggn2.202100047 |
Ejemplares similares
-
Primary mitochondrial disease in the US: Data from patients and physicians' perspective on health care delivery
por: Karaa, Amel, et al.
Publicado: (2019) -
Safety of drug use in patients with a primary mitochondrial disease: An international Delphi‐based consensus
por: De Vries, Maaike C., et al.
Publicado: (2020) -
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial
por: Karaa, Amel, et al.
Publicado: (2023) -
Navigating Life With Primary Mitochondrial Myopathies: The Importance of the Patient Voice and Implications for Clinical Practice
por: Moore, Margaret, et al.
Publicado: (2023) -
Outcome measures for children with mitochondrial disease: consensus recommendations for future studies from a Delphi-based international workshop
por: Koene, Saskia, et al.
Publicado: (2018)